Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells

Area of Science:

• Oncology
• Medicinal Chemistry
• Molecular Biology

Background:

• Pancreatic cancer (PC) presents a significant global health challenge due to its high mortality rate and limited therapeutic efficacy.
• Resveratrol (RSV), a natural polyphenol, exhibits anticancer properties, but its therapeutic potential is often constrained by suboptimal pharmacokinetic characteristics.
• There is an unmet need for novel, low-toxicity agents with improved efficacy for pancreatic cancer treatment.

Purpose of the Study:

• To synthesize and evaluate novel resveratrol analogues for their antiproliferative activity against pancreatic cancer cell lines.
• To investigate the underlying mechanisms of action of the most potent RSV derivative.
• To assess the compound's physicochemical properties, including stability, lipophilicity, and selectivity.

Main Methods:

• Synthesis of novel resveratrol analogues.
• Assessment of antiproliferative effects using cell viability assays.
• Flow cytometry and immunoblot analysis to evaluate DNA damage, apoptosis, cell cycle progression, and stem-like cell markers (CD133+, EpCAM+).
• Evaluation of cytotoxicity against normal human fibroblasts (HFF-1) and assessment of plasma stability and lipophilicity.

Main Results:

• A specific RSV derivative demonstrated potent antiproliferative activity across a panel of PC cell lines.
• The compound induced DNA damage, apoptosis, and cell cycle arrest, alongside reducing the CD133+EpCAM+ stem-like cell subpopulation and clonogenicity.
• The derivative exhibited high selectivity, with negligible toxicity to normal HFF-1 cells, and possessed enhanced lipophilicity and plasma stability compared to RSV.

Conclusions:

• The synthetic RSV analogue displays significant potential as an anticancer agent for pancreatic cancer.
• Its mechanism of action involves multiple pathways, including DNA damage and apoptosis induction, targeting cancer stem cells.
• Improved physicochemical properties suggest enhanced bioavailability and therapeutic applicability, warranting further investigation for PC treatment.